Company: CMND
Filing Date: 2025-09-19
Form Type: F-1
Source: 0001213900-25-089545
Chunk: 41

Company: Clearmind Medicine Inc.
Filing Date: 2025-09-19
Form: F-1
Chunk 41
---
us
effective until the earlier of (i) the date on which the securities may be resold by the selling shareholders without registration and
without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for us to be in compliance with
the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities
have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in
certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.

Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market
making activities with respect to the common shares for the applicable restricted period, as defined in Regulation M, prior to the commencement
of the distribution. In addition, the selling shareholders will be subject to applicable provisions of the Exchange Act and the rules
and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common shares by the selling
shareholders or any other person. We will make copies of this prospectus available to the selling shareholders and have informed them
of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule
172 under the Securities Act).

<div align='center'>EXPENSES OF THIS OFFERING</div>

Set forth below is an itemization
of the total expenses, excluding placement agent discounts, expected to be incurred in connection with the offer and sale of the securities
offered by us. With the exception of the SEC registration fee, all amounts are estimates:

| SEC registration fee         |     | $ |  2,632 |
| Legal fees and expenses      |     |   | 15,000 |
| Accounting fees and expenses |     |   |  8,000 |
| Total                        |     | $ | 25,632 |

<div align='center'>LEGAL MATTERS</div>

The validity of the issuance
of our common shares offered in this prospectus and certain other matters of Canadian law will be passed upon for us by